Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126363231 | 12636323 | 1 | I | 2012 | 20160727 | 20160809 | 20160809 | EXP | BE-MLMSERVICE-20160721-0358575-11 | BE-STRIDES ARCOLAB LIMITED-2016SP011057 | STRIDES | 0.00 | Y | 0.00000 | 20160809 | OT | GB | BE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126363231 | 12636323 | 1 | I | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | UNK | U | U | 0 | |||||||||
| 126363231 | 12636323 | 2 | I | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 500 MG, BID | U | U | 0 | 500 | MG | |||||||
| 126363231 | 12636323 | 3 | PS | TACROLIMUS. | TACROLIMUS | 1 | UNK | U | U | 90687 | |||||||||
| 126363231 | 12636323 | 4 | I | TACROLIMUS. | TACROLIMUS | 1 | 0.5 MG, BID | U | U | 90687 | .5 | MG | |||||||
| 126363231 | 12636323 | 5 | I | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | UNK | 0 | |||||||||||
| 126363231 | 12636323 | 6 | I | FENTANYL. | FENTANYL | 1 | Transdermal | UNK | 0 | ||||||||||
| 126363231 | 12636323 | 7 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126363231 | 12636323 | 8 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 4 MG PER DAY | 0 | 4 | MG | |||||||||
| 126363231 | 12636323 | 9 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 500 MG, UNK | 0 | 500 | MG | ||||||||
| 126363231 | 12636323 | 10 | C | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | UNK | 0 | |||||||||||
| 126363231 | 12636323 | 11 | C | COTRIMAXAZOLE | 2 | Oral | SULFAMETHOXAZOLE 400MG, TRIMETHOPRIM 80MG | 0 | |||||||||||
| 126363231 | 12636323 | 12 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | 0 | 500 | MG | ||||||||
| 126363231 | 12636323 | 13 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 500 MG, BID | 0 | 500 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126363231 | 12636323 | 1 | Immunosuppression |
| 126363231 | 12636323 | 3 | Immunosuppression |
| 126363231 | 12636323 | 5 | Product used for unknown indication |
| 126363231 | 12636323 | 6 | Thoracic vertebral fracture |
| 126363231 | 12636323 | 7 | Immunosuppression |
| 126363231 | 12636323 | 8 | Transplant rejection |
| 126363231 | 12636323 | 10 | Thoracic vertebral fracture |
| 126363231 | 12636323 | 11 | Pseudomonas infection |
| 126363231 | 12636323 | 12 | Glucose tolerance impaired |
| 126363231 | 12636323 | 13 | Sinusitis bacterial |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126363231 | 12636323 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126363231 | 12636323 | Drug interaction | |
| 126363231 | 12636323 | Hyponatraemia | |
| 126363231 | 12636323 | Stupor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126363231 | 12636323 | 5 | 2012 | 2012 | 0 | |
| 126363231 | 12636323 | 6 | 2012 | 2012 | 0 | |
| 126363231 | 12636323 | 9 | 2012 | 0 |